Evidence map›Paper›PMID 37726653›Full record

ArticleBMC bioinformatics2023

Bulk brain tissue cell-type deconvolution with bias correction for single-nuclei RNA sequencing data using DeTREM.

Nicholas K O'Neill, Thor D Stein, Junming Hu, Habbiburr Rehman, Joshua D Campbell, Masanao Yajima, Xiaoling Zhang, Lindsay A Farrer

Abstract read
In one paragraph

Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Cognitive resilience to Alzheimer's disease characterized by cell-type abundance.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nicholas K O'NeillBioinformatics Program, Boston University, Boston, MA, USA.
Thor D SteinDepartment of Pathology and Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Junming HuBioinformatics Program, Boston University, Boston, MA, USA.
Habbiburr RehmanDepartment of Medicine (Biomedical Genetics), Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Joshua D CampbellBioinformatics Program, Boston University, Boston, MA, USA.
Masanao YajimaDepartment of Mathematics and Statistics, Boston University, Boston, MA, USA.
Xiaoling ZhangBioinformatics Program, Boston University, Boston, MA, USA. zhangxl@bu.edu.
Lindsay A FarrerBioinformatics Program, Boston University, Boston, MA, USA. farrer@bu.edu.

Funding

The Alzheimer Disease Sequence Analysis CollaborativeU01AG058654 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI BUSH, WILLIAM S, FARRER, LINDSAY A. · 2018 to 2022
$14.6M
Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathologyU01AG072577 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L, ZHANG, XIAOLING · 2021 to 2025
$3.8M
The role of N6-methyladenosine modified RNA in Alzheimer's disease: Equipment SupplementR01AG080810 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Benjamin L Wolozin, Xiaoling Zhang · 2023 to 2026
$3.2M
BLRD VA I01 BX005161NIA NIH HHS R01 AG080810NIA NIH HHS U01-AG058654NIA NIH HHS U01 AG072577NIA NIH HHS U01-AG072577
6 · The paper itself

Abstract

backgroundQuantifying cell-type abundance in bulk tissue RNA-sequencing enables researchers to better understand complex systems. Newer deconvolution methodologies, such as MuSiC, use cell-type signatures derived from single-cell RNA-sequencing (scRNA-seq) data to make these calculations. Single-nuclei RNA-sequencing (snRNA-seq) reference data can be used instead of scRNA-seq data for tissues such as human brain where single-cell data are difficult to obtain, but accuracy suffers due to sequencing differences between the technologies.

resultsWe propose a modification to MuSiC entitled 'DeTREM' which compensates for sequencing differences between the cell-type signature and bulk RNA-seq datasets in order to better predict cell-type fractions. We show DeTREM to be more accurate than MuSiC in simulated and real human brain bulk RNA-sequencing datasets with various cell-type abundance estimates. We also compare DeTREM to SCDC and CIBERSORTx, two recent deconvolution methods that use scRNA-seq cell-type signatures. We find that they perform well in simulated data but produce less accurate results than DeTREM when used to deconvolute human brain data.

conclusionDeTREM improves the deconvolution accuracy of MuSiC and outperforms other deconvolution methods when applied to snRNA-seq data. DeTREM enables accurate cell-type deconvolution in situations where scRNA-seq data are not available. This modification improves characterization cell-type specific effects in brain tissue and identification of cell-type abundance differences under various conditions.

Indexed as

BrainRNABase SequenceHumansRNA-SeqRNA, Small NuclearRNARNA, Small NuclearBrain cell-typesDeconvolutionMuSiCSingle-nuclei RNA sequencing

Identifiers

PMID37726653
PMCPMC10507917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.